Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression

Lizza E.L. Hendriks; Jordi Remon; Benjamin Besse

doi:10.1016/j.cllc.2021.05.012

Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression

Lizza E.L. Hendriks, Jordi Remon, Benjamin Besse

Résultats de recherche: Contribution à un journal › !!Comment/debate

langue originale	Anglais
Pages (de - à)	e87-e89
journal	Clinical Lung Cancer
Volume	23
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.cllc.2021.05.012
état	Publié - 1 mars 2022

Accès au document

10.1016/j.cllc.2021.05.012

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{4fd694f3cf794d2fbb0a32b6e123c8b7,

title = "Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression",

keywords = "Immune checkpoint inhibition, Programmed death-ligand 1, non-small cell lung cancer, phase III clinical trials, real-world data",

author = "Hendriks, {Lizza E.L.} and Jordi Remon and Benjamin Besse",

note = "Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.",

year = "2022",

month = mar,

day = "1",

doi = "10.1016/j.cllc.2021.05.012",

language = "English",

volume = "23",

pages = "e87--e89",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

number = "2",

}

TY - JOUR

T1 - Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non–Small-Cell Lung Cancer and High PD-L1 Expression

AU - Hendriks, Lizza E.L.

AU - Remon, Jordi

AU - Besse, Benjamin

N1 - Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

PY - 2022/3/1

Y1 - 2022/3/1

KW - Immune checkpoint inhibition

KW - Programmed death-ligand 1

KW - non-small cell lung cancer

KW - phase III clinical trials

KW - real-world data

UR - http://www.scopus.com/inward/record.url?scp=85110495434&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2021.05.012

DO - 10.1016/j.cllc.2021.05.012

M3 - Comment/debate

C2 - 34275764

AN - SCOPUS:85110495434

SN - 1525-7304

VL - 23

SP - e87-e89

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 2

ER -